Clinical Trial Update: 18-F-Fluoroacetate as PET Imaging Agent [Phase 1]

View source ↗

Summary

A Phase 1 trial of the PET imaging agent 18-F-Fluoroacetate sponsored by MD Anderson Cancer Center was withdrawn, with conditions including brain cancer, breast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Cancer
• Breast Cancer
• Prostate Cancer

Drugs mentioned

• 18-F-Fluoroacetate (18F-fluoroacetate)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Brain Cancer, Breast Cancer | Phase 1 | Status: WITHDRAWN